Back to results
US 2012/0231085 A1Published application
Controlled release compositions of gamma-hydroxybutyrate
AssigneeSupernus Pharmaceuticals, Inc.
InventorsLikan Liang, Niraj Shah, Padmanabh P. Bhatt, Scott Ibrahim
Life of this patent
Estimating the term…
Abstract
The present invention is directed to oral pulse-release pharmaceutical dosage form containing an immediate release component of gamma-hydroxybutyric acid, and one or more delayed/controlled release components of gamma-hydroxybutyric acid.
Claims26
-56. (canceled)
An oral pharmaceutical dosage form, comprising (a) an immediate release component comprising gamma-hydroxybutyric acid (GHB), and (b) a delayed release component comprising GHB.
An oral pharmaceutical composition, comprising a delayed release component comprising gamma-hydroxybutyric acid (GHB).
Dependencies are inferred from the claim text.